淋化MSC-EV通过调节JAK/STAT通路来减轻COVID-19的病原性
Nesrine Ebrahim1,2,3,4, Hajir A Al Saihati5, Zahraa Alali6
1Department of Medical Histology and Cell Biology Faculty of Medicine, Benha University, Benha, Egypt.
Stem cell research & therapy
|May 14, 2025
概括
淋化介质干细胞衍生的细胞外囊泡 (MSC-EVs) 通过抑制JAK/STAT通路,显示出治疗COVID-19的潜力. 在仓鼠模型中,MSC-EVs减少了炎症并改善了结果,提供了一个有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 生物技术是生物技术.
背景情况:
- 在严重的COVID-19中,JAK/STAT通路和相关的细胞因子风暴是关键.
- STAT3促进炎症,使其抑制成为治疗点.
- 介细胞干细胞衍生的细胞外囊 (MSC-EVs) 通过miRNA载荷调节免疫反应.
研究的目的:
- 在COVID-19模型中研究冷凍化MSC-EVs在抑制JAK/STAT通路中的有效性.
- 评估MSC-EVs在COVID-19管理中的治疗潜力.
主要方法:
- 叙利亚仓鼠感染了SARS-CoV-2并用冷化MSC-EVs进行治疗.
- 肺部组织通过组织病理学,形态测量和西式涂抹分析.
- 评估了病毒标位和miRNA表达.
主要成果:
- 施用MSC-EV可在肺组织中调高特定的miRNAs (例如miRNA-146a,miRNA-124).
- MSC-EVs显著损害了STAT3/STAT1信号通路的激活.
- 治疗减少了COVID-19相关的细胞因子风暴和凝血病.
结论:
- 通过准JAK/STAT途径,MSC-EV显示出减轻COVID-19病原性的潜力.
- 需要进一步的研究来阐明MSC-EV机制和COVID-19的临床应用.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Immune Response Against Viral Pathogens
705
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
705
cAMP-dependent Protein Kinase Pathways
6.0K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.0K
EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K


